Management reshuffle. About time. Same concern as Lape, more wages better add increased value.
Love the change of tack from catalyst being the announcement to near-term driver (eek lets hope so).
Slightly concerned about this focus jump. I thought the drive going forward for Satipharm was the Aus markets as they have been sitting in the european markets the past year apparently doing jack and now require a new CEO.
Fingers crossed on a positive result soon.
MMJ Price at posting:
22.0¢ Sentiment: Hold Disclosure: Held
